European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of Cancer
mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of
Read moremAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of
Read moreThink Research Sees 633 Per Cent Growth in Demand for VirtualCare Telemedicine Platform During COVID-19 Pandemic Canada NewsWire /NOT FOR
Read moreCanada NewsWire TORONTO,Jan. 27, 2021/CNW/ –Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased to
Read more